尊龙凯时
About us
尊龙凯时:Our Values
尊龙凯时:Development Milestone
Products
尊龙凯时:Product List for API
尊龙凯时:Recommended API
尊龙凯时:Product list for Chemicals and Intermediates
Product list for Chemicals and Intermediates
News
尊龙凯时:Contract Manufacturing
尊龙凯时:API and Pharmaceutical Intermediates
尊龙凯时:OTC and Generics
尊龙凯时:Investor Relation
尊龙凯时:PERIODIC REPORT
尊龙凯时:INTERIM REPORT
尊龙凯时:INVESTORS SERVICE
尊龙凯时:Contact Us
About us
News
尊龙凯时:Investor Relation
Products
尊龙凯时:Contract Manufacturing
尊龙凯时:Contact Us
Investor Relation
Investor Relation
尊龙凯时:PERIODIC REPORT
尊龙凯时:INTERIM REPORT
尊龙凯时:INVESTORS SERVICE
Overseas Regulatory Announcement-Announcement on Having Obtained the Notification of Approval of Supplementary Drug Application and Other Relevant Information
2025-04-14
Overseas Regulatory Announcement-Announcement on Aminophylline Tablets Passing the Generic Drugs Consistency Evaluation
2025-04-14
Announcement Notice of Board Meeting
2025-04-14
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2025
2025-04-02
Final Dividend for the Year Ended 31 December 2024
2025-03-28
Proposed Amendments to the Articles of Association
2025-03-28
Announcement Notice of Board Meeting
2025-03-14
Overseas Regulatory Announcement-Announcement on Pentazocine Injection Having Obtained the Drug Registration Certificate
2025-03-11
Overseas Regulatory Announcement-Announcement on Having Obtained the Notification of Approval of Supplementary Drug Application and Other Relevant Information
2025-03-03
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 28 February 2025
2025-03-03
<
1
2
3
4
5
6
7
...
>
